InsiderTrades

Form 4 for MRNA Moderna

Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-27 · accession 0001127602-25-015904 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-05-29 2025-05-27+ MRNA Hoge Stephen Pres F - Tax $26.41 -990 1.45M -0.1% -$26.1K
DM 2025-05-29 2025-05-27+ MRNA Hoge Stephen Pres M - OptEx — +2,046 1.45M +0.1% —
DM 2025-05-29 2025-05-27+ MRNA Hoge Stephen Pres M - OptEx $0.00 -2,046 15.8K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-28 F D 295 $26.76 1,451,783 D — —
2 Common Common Stock 2025-05-27 M A 1,436 — 1,452,163 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
3 Common Common Stock 2025-05-27 F D 695 $26.26 1,451,468 D — —
4 Common Common Stock 2025-05-28 M A 610 — 1,452,078 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
5 Derivative Restricted Stock Units 2025-05-28 M D 610 $0.00 4,274 D — · — to — 610 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
6 Derivative Restricted Stock Units 2025-05-27 M D 1,436 $0.00 15,805 D — · — to — 1,436 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.